Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
NCT07177209 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2026-05-14
Summary
Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population
Conditions
Interventions
- DRUG
-
Non-Interventional Study
As provided in real world practice
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-01
- Primary Completion
- 2026-07-31
- Completion
- 2026-07-31
- FDA Drug
- Yes
Countries
- United Kingdom
Study Locations
More Related Trials
-
Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis
NCT01282905 ·Status: COMPLETED
-
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis
NCT04926103 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis
NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2
-
LFMT vs Placebo in New Biologic Start for Ulcerative Colitis
NCT05327790 ·Status: RECRUITING ·Phase: PHASE2
-
Fecal Biomarker Study for Patients With Ulcerative Colitis
NCT00780507 ·Status: COMPLETED
-
Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
NCT04882007 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
NCT01562314 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis
NCT05549323 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
NCT02958865 ·Status: COMPLETED ·Phase: PHASE2
-
Protocol for Optimizing Colonoscopy Preparation in Patients With Inflammatory Bowel Disease
NCT04411017 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Study of ONO-4819CD for Ulcerative Colitis
NCT00296556 ·Status: TERMINATED ·Phase: PHASE2
-
Use of the Ulcerative Colitis Diet for Induction of Remission
NCT02217722 ·Status: TERMINATED ·Phase: NA
-
Determination of the Optimal Treatment Target in Ulcerative Colitis
NCT04259138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients
NCT03773952 ·Status: COMPLETED ·Phase: PHASE2
-
GSK2982772 Study in Subjects With Ulcerative Colitis
NCT02903966 ·Status: COMPLETED ·Phase: PHASE2
-
Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis
NCT03808506 ·Status: WITHDRAWN
-
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
NCT06975722 ·Status: RECRUITING ·Phase: PHASE2
-
Critical State of "Remission-Recurrence" of Ulcerative Colitis
NCT06694883 ·Status: RECRUITING
-
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
NCT00659802 ·Status: COMPLETED ·Phase: PHASE2
-
Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases
NCT02179372 ·Status: COMPLETED ·Phase: NA
-
FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
NCT00064441 ·Status: COMPLETED ·Phase: PHASE3
-
Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
NCT05702879 ·Status: RECRUITING
-
A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
NCT03844932 ·Status: TERMINATED ·Phase: PHASE2
-
Nicotinamide Riboside in Ulcerative Colitis
NCT05561738 ·Status: RECRUITING ·Phase: NA